[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"$fCYMTeqxJfOwPN5esTKx8dDeyVBIxpYb9PVLdvQAjaRA":3},{"sponsor":4,"sponsorVariants":5,"totalTrials":6,"truncated":7,"activeTrials":8,"phase3Count":9,"totalEnrollment":10,"activePrograms":11,"nonDrugCount":12,"topConditions":13,"upcomingReadouts":33,"phaseBuckets":74,"rows":81},"Ciusss de L'Est de l'Île de Montréal",[4],87,false,30,2,24022,16,55,[14,17,20,23,25,27,29,31],{"name":15,"count":16},"Anesthesia",14,{"name":18,"count":19},"Nociceptive Pain",4,{"name":21,"count":22},"Chronic Pain",3,{"name":24,"count":22},"Postoperative Pain",{"name":26,"count":22},"Auditory Hallucination, Verbal",{"name":28,"count":22},"Treatment-resistant Schizophrenia",{"name":30,"count":9},"Virtual Reality",{"name":32,"count":9},"Peritoneal Dialysis (PD)",[34,39,44,49,54,59,64,69],{"nctId":35,"briefTitle":36,"date":37,"intervention":38},"NCT06291363","Impact of Administration of Esmolol on Nociception Level-guided Control of Nociception.","2025-03-03","Esmolol Hydrochloride",{"nctId":40,"briefTitle":41,"date":42,"intervention":43},"NCT06684197","The Impact of a Dexmedetomidine Perfusion on Intraoperative Remifentanil Consumption","2025-11","Dexmedetomidine",{"nctId":45,"briefTitle":46,"date":47,"intervention":48},"NCT03596424","Dexmedetomidine and Ketamine in VATS Surgery","2025-12-01","Ketamine Hydrochloride",{"nctId":50,"briefTitle":51,"date":52,"intervention":53},"NCT05534945","PIB for Post-operative Analgesia After Laparotomy : Determining the Optimum Dose","2026-07","Programmed intermittent epidural bolus 5 ml",{"nctId":55,"briefTitle":56,"date":57,"intervention":58},"NCT05713877","Melatonin for Treatment of Delirium in Critically Ill Adult Patients","2026-12-30","Melatonin",{"nctId":60,"briefTitle":61,"date":62,"intervention":63},"NCT03913026","UM171 Expanded Cord Blood In Patients With High-Risk Acute Leukemia\u002FMyelodysplasia","2027-06","Transplant with an expanded ECT-001 cord blood",{"nctId":65,"briefTitle":66,"date":67,"intervention":68},"NCT07301866","A Study Testing an Improved Dose of UM171 to Help Make Cord Blood Transplants More Effective and Safe.","2027-10","ECT-001-CB",{"nctId":70,"briefTitle":71,"date":72,"intervention":73},"NCT05913674","Technical Feasibility of Modified Early Post-Operative Intraperitoneal Chemotherapy (mEPIC)","2028-05","Modified early post-operative intraperitoneal chemotherapy",[75,76,77,78,79,80],"EARLY_PHASE1","PHASE1","PHASE2","PHASE3","PHASE4","NA",[82,108,126,150,174,194,216,254,278,296,314,343,361,379,397,415,433,457,475,503,521,548,566,591,617,635,661,679,707,725,763,798,816,834,852,878,912,938,956,981,1006,1030,1054,1072,1100,1118,1146,1164,1190,1219,1237,1255,1273,1300,1318],{"intervention":38,"totalTrials":83,"cells":84},1,{"EARLY_PHASE1":85,"PHASE1":88,"PHASE2":90,"PHASE3":92,"PHASE4":94,"NA":106},{"trials":86,"activeCount":87},[],0,{"trials":89,"activeCount":87},[],{"trials":91,"activeCount":87},[],{"trials":93,"activeCount":87},[],{"trials":95,"activeCount":83,"soonestReadout":37},[96],{"nctId":35,"briefTitle":36,"status":97,"phases":98,"primaryCompletion":37,"completion":99,"start":100,"enrollment":101,"conditions":102,"interventions":104},"RECRUITING",[79],"2025-03-04","2024-04-16",64,[103,15,18],"Opioid Use, Unspecified",[38,105],"Saline",{"trials":107,"activeCount":87},[],{"intervention":105,"totalTrials":83,"cells":109},{"EARLY_PHASE1":110,"PHASE1":112,"PHASE2":114,"PHASE3":116,"PHASE4":118,"NA":124},{"trials":111,"activeCount":87},[],{"trials":113,"activeCount":87},[],{"trials":115,"activeCount":87},[],{"trials":117,"activeCount":87},[],{"trials":119,"activeCount":83,"soonestReadout":37},[120],{"nctId":35,"briefTitle":36,"status":97,"phases":121,"primaryCompletion":37,"completion":99,"start":100,"enrollment":101,"conditions":122,"interventions":123},[79],[103,15,18],[38,105],{"trials":125,"activeCount":87},[],{"intervention":68,"totalTrials":83,"cells":127},{"EARLY_PHASE1":128,"PHASE1":130,"PHASE2":132,"PHASE3":144,"PHASE4":146,"NA":148},{"trials":129,"activeCount":87},[],{"trials":131,"activeCount":87},[],{"trials":133,"activeCount":83,"soonestReadout":67},[134],{"nctId":65,"briefTitle":66,"status":97,"phases":135,"primaryCompletion":67,"completion":136,"start":137,"enrollment":138,"conditions":139,"interventions":143},[76,77],"2028-03","2025-10-06",7,[140,141,142],"Acute Leukemia, High Risk","Myelodysplastic Syndromes, High Risk","Hematologic Malignancy Requiring an Allogeneic Hematopoietic Stem Cell Transplant Lacking a Donor",[68],{"trials":145,"activeCount":87},[],{"trials":147,"activeCount":87},[],{"trials":149,"activeCount":87},[],{"intervention":73,"totalTrials":83,"cells":151},{"EARLY_PHASE1":152,"PHASE1":154,"PHASE2":156,"PHASE3":168,"PHASE4":170,"NA":172},{"trials":153,"activeCount":87},[],{"trials":155,"activeCount":87},[],{"trials":157,"activeCount":83,"soonestReadout":72},[158],{"nctId":70,"briefTitle":71,"status":97,"phases":159,"primaryCompletion":72,"completion":160,"start":161,"enrollment":162,"conditions":163,"interventions":167},[77],"2028-09","2026-05-01",25,[164,165,166],"Peritoneal Carcinomatosis","Appendiceal Neoplasms","Colorectal Cancer Metastatic",[73],{"trials":169,"activeCount":87},[],{"trials":171,"activeCount":87},[],{"trials":173,"activeCount":87},[],{"intervention":58,"totalTrials":83,"cells":175},{"EARLY_PHASE1":176,"PHASE1":178,"PHASE2":180,"PHASE3":188,"PHASE4":190,"NA":192},{"trials":177,"activeCount":87},[],{"trials":179,"activeCount":87},[],{"trials":181,"activeCount":83,"soonestReadout":57},[182],{"nctId":55,"briefTitle":56,"status":97,"phases":183,"primaryCompletion":57,"completion":57,"start":184,"enrollment":8,"conditions":185,"interventions":187},[77],"2023-02-01",[186],"Delirium",[58],{"trials":189,"activeCount":87},[],{"trials":191,"activeCount":87},[],{"trials":193,"activeCount":87},[],{"intervention":63,"totalTrials":83,"cells":195},{"EARLY_PHASE1":196,"PHASE1":198,"PHASE2":200,"PHASE3":210,"PHASE4":212,"NA":214},{"trials":197,"activeCount":87},[],{"trials":199,"activeCount":87},[],{"trials":201,"activeCount":83,"soonestReadout":62},[202],{"nctId":60,"briefTitle":61,"status":203,"phases":204,"primaryCompletion":62,"completion":62,"start":205,"enrollment":8,"conditions":206,"interventions":209},"ACTIVE_NOT_RECRUITING",[77],"2019-04-01",[207,208],"High Risk Hematologic Malignancy","Cord Blood Transplant",[63],{"trials":211,"activeCount":87},[],{"trials":213,"activeCount":87},[],{"trials":215,"activeCount":87},[],{"intervention":43,"totalTrials":9,"cells":217},{"EARLY_PHASE1":218,"PHASE1":220,"PHASE2":222,"PHASE3":224,"PHASE4":226,"NA":228},{"trials":219,"activeCount":87},[],{"trials":221,"activeCount":87},[],{"trials":223,"activeCount":87},[],{"trials":225,"activeCount":87},[],{"trials":227,"activeCount":87},[],{"trials":229,"activeCount":83,"soonestReadout":42},[230,243],{"nctId":231,"briefTitle":232,"status":233,"phases":234,"primaryCompletion":235,"completion":235,"start":236,"enrollment":237,"conditions":238,"interventions":242},"NCT05615194","The Impact of a Single Dexmedetomidine Bolus on Intraoperative Sevoflurane Consumption (DEXHALE)","UNKNOWN",[80],"2023-09","2022-12-05",84,[239,43,240,241],"Inhalation Anesthesia","Sevoflurane","Laparoscopy",[43],{"nctId":40,"briefTitle":41,"status":244,"phases":245,"primaryCompletion":42,"completion":42,"start":246,"enrollment":247,"conditions":248,"interventions":253},"NOT_YET_RECRUITING",[80],"2024-11",72,[43,249,250,251,252],"Total Intravenous Anesthesia","Remifentanil Consumption","Remifentanil","Laparoscopic Abdominal Surgery",[43],{"intervention":48,"totalTrials":83,"cells":255},{"EARLY_PHASE1":256,"PHASE1":258,"PHASE2":260,"PHASE3":262,"PHASE4":264,"NA":266},{"trials":257,"activeCount":87},[],{"trials":259,"activeCount":87},[],{"trials":261,"activeCount":87},[],{"trials":263,"activeCount":87},[],{"trials":265,"activeCount":87},[],{"trials":267,"activeCount":83,"soonestReadout":47},[268],{"nctId":45,"briefTitle":46,"status":97,"phases":269,"primaryCompletion":47,"completion":270,"start":271,"enrollment":272,"conditions":273,"interventions":275},[80],"2026-07-01","2018-02-01",120,[24,274],"Opioid Use",[48,276,277],"Dexmedetomidine Hydrochloride","dexmedetomidine Hydrochloride and Ketamine Hydrochloride",{"intervention":276,"totalTrials":83,"cells":279},{"EARLY_PHASE1":280,"PHASE1":282,"PHASE2":284,"PHASE3":286,"PHASE4":288,"NA":290},{"trials":281,"activeCount":87},[],{"trials":283,"activeCount":87},[],{"trials":285,"activeCount":87},[],{"trials":287,"activeCount":87},[],{"trials":289,"activeCount":87},[],{"trials":291,"activeCount":83,"soonestReadout":47},[292],{"nctId":45,"briefTitle":46,"status":97,"phases":293,"primaryCompletion":47,"completion":270,"start":271,"enrollment":272,"conditions":294,"interventions":295},[80],[24,274],[48,276,277],{"intervention":277,"totalTrials":83,"cells":297},{"EARLY_PHASE1":298,"PHASE1":300,"PHASE2":302,"PHASE3":304,"PHASE4":306,"NA":308},{"trials":299,"activeCount":87},[],{"trials":301,"activeCount":87},[],{"trials":303,"activeCount":87},[],{"trials":305,"activeCount":87},[],{"trials":307,"activeCount":87},[],{"trials":309,"activeCount":83,"soonestReadout":47},[310],{"nctId":45,"briefTitle":46,"status":97,"phases":311,"primaryCompletion":47,"completion":270,"start":271,"enrollment":272,"conditions":312,"interventions":313},[80],[24,274],[48,276,277],{"intervention":53,"totalTrials":83,"cells":315},{"EARLY_PHASE1":316,"PHASE1":318,"PHASE2":320,"PHASE3":322,"PHASE4":324,"NA":326},{"trials":317,"activeCount":87},[],{"trials":319,"activeCount":87},[],{"trials":321,"activeCount":87},[],{"trials":323,"activeCount":87},[],{"trials":325,"activeCount":87},[],{"trials":327,"activeCount":83,"soonestReadout":52},[328],{"nctId":50,"briefTitle":51,"status":97,"phases":329,"primaryCompletion":52,"completion":330,"start":331,"enrollment":332,"conditions":333,"interventions":337},[80],"2026-12","2022-12-01",60,[334,335,336],"Acute Post Operative Pain","Laparotomy","Epidural Analgesia",[53,338,339,340,341,342],"Programmed intermittent epidural bolus 6 ml","Programmed intermittent epidural bolus 7 ml","Programmed intermittent epidural bolus 8 ml","Programmed intermittent epidural bolus 9 ml","Programmed intermittent epidural bolus 10 ml",{"intervention":338,"totalTrials":83,"cells":344},{"EARLY_PHASE1":345,"PHASE1":347,"PHASE2":349,"PHASE3":351,"PHASE4":353,"NA":355},{"trials":346,"activeCount":87},[],{"trials":348,"activeCount":87},[],{"trials":350,"activeCount":87},[],{"trials":352,"activeCount":87},[],{"trials":354,"activeCount":87},[],{"trials":356,"activeCount":83,"soonestReadout":52},[357],{"nctId":50,"briefTitle":51,"status":97,"phases":358,"primaryCompletion":52,"completion":330,"start":331,"enrollment":332,"conditions":359,"interventions":360},[80],[334,335,336],[53,338,339,340,341,342],{"intervention":339,"totalTrials":83,"cells":362},{"EARLY_PHASE1":363,"PHASE1":365,"PHASE2":367,"PHASE3":369,"PHASE4":371,"NA":373},{"trials":364,"activeCount":87},[],{"trials":366,"activeCount":87},[],{"trials":368,"activeCount":87},[],{"trials":370,"activeCount":87},[],{"trials":372,"activeCount":87},[],{"trials":374,"activeCount":83,"soonestReadout":52},[375],{"nctId":50,"briefTitle":51,"status":97,"phases":376,"primaryCompletion":52,"completion":330,"start":331,"enrollment":332,"conditions":377,"interventions":378},[80],[334,335,336],[53,338,339,340,341,342],{"intervention":340,"totalTrials":83,"cells":380},{"EARLY_PHASE1":381,"PHASE1":383,"PHASE2":385,"PHASE3":387,"PHASE4":389,"NA":391},{"trials":382,"activeCount":87},[],{"trials":384,"activeCount":87},[],{"trials":386,"activeCount":87},[],{"trials":388,"activeCount":87},[],{"trials":390,"activeCount":87},[],{"trials":392,"activeCount":83,"soonestReadout":52},[393],{"nctId":50,"briefTitle":51,"status":97,"phases":394,"primaryCompletion":52,"completion":330,"start":331,"enrollment":332,"conditions":395,"interventions":396},[80],[334,335,336],[53,338,339,340,341,342],{"intervention":341,"totalTrials":83,"cells":398},{"EARLY_PHASE1":399,"PHASE1":401,"PHASE2":403,"PHASE3":405,"PHASE4":407,"NA":409},{"trials":400,"activeCount":87},[],{"trials":402,"activeCount":87},[],{"trials":404,"activeCount":87},[],{"trials":406,"activeCount":87},[],{"trials":408,"activeCount":87},[],{"trials":410,"activeCount":83,"soonestReadout":52},[411],{"nctId":50,"briefTitle":51,"status":97,"phases":412,"primaryCompletion":52,"completion":330,"start":331,"enrollment":332,"conditions":413,"interventions":414},[80],[334,335,336],[53,338,339,340,341,342],{"intervention":342,"totalTrials":83,"cells":416},{"EARLY_PHASE1":417,"PHASE1":419,"PHASE2":421,"PHASE3":423,"PHASE4":425,"NA":427},{"trials":418,"activeCount":87},[],{"trials":420,"activeCount":87},[],{"trials":422,"activeCount":87},[],{"trials":424,"activeCount":87},[],{"trials":426,"activeCount":87},[],{"trials":428,"activeCount":83,"soonestReadout":52},[429],{"nctId":50,"briefTitle":51,"status":97,"phases":430,"primaryCompletion":52,"completion":330,"start":331,"enrollment":332,"conditions":431,"interventions":432},[80],[334,335,336],[53,338,339,340,341,342],{"intervention":434,"totalTrials":83,"cells":435},"Propofol",{"EARLY_PHASE1":436,"PHASE1":438,"PHASE2":440,"PHASE3":442,"PHASE4":444,"NA":455},{"trials":437,"activeCount":87},[],{"trials":439,"activeCount":87},[],{"trials":441,"activeCount":87},[],{"trials":443,"activeCount":87},[],{"trials":445,"activeCount":87},[446],{"nctId":447,"briefTitle":448,"status":449,"phases":450,"primaryCompletion":451,"completion":451,"start":452,"enrollment":332,"conditions":453,"interventions":454},"NCT04567160","NOL Index to Compare the Intraoperative Analgesic Effect of Propofol Versus Sevoflurane","COMPLETED",[79],"2022-03-17","2020-10-01",[18,15],[434,240],{"trials":456,"activeCount":87},[],{"intervention":240,"totalTrials":83,"cells":458},{"EARLY_PHASE1":459,"PHASE1":461,"PHASE2":463,"PHASE3":465,"PHASE4":467,"NA":473},{"trials":460,"activeCount":87},[],{"trials":462,"activeCount":87},[],{"trials":464,"activeCount":87},[],{"trials":466,"activeCount":87},[],{"trials":468,"activeCount":87},[469],{"nctId":447,"briefTitle":448,"status":449,"phases":470,"primaryCompletion":451,"completion":451,"start":452,"enrollment":332,"conditions":471,"interventions":472},[79],[18,15],[434,240],{"trials":474,"activeCount":87},[],{"intervention":476,"totalTrials":83,"cells":477},"Carbetocin bolus",{"EARLY_PHASE1":478,"PHASE1":480,"PHASE2":482,"PHASE3":484,"PHASE4":486,"NA":501},{"trials":479,"activeCount":87},[],{"trials":481,"activeCount":87},[],{"trials":483,"activeCount":87},[],{"trials":485,"activeCount":87},[],{"trials":487,"activeCount":87},[488],{"nctId":489,"briefTitle":490,"status":449,"phases":491,"primaryCompletion":492,"completion":493,"start":494,"enrollment":495,"conditions":496,"interventions":499},"NCT03404544","Impact of Carbetocin Administration on Heart Rate When Given as an Infusion Versus as a Bolus.",[79],"2020-01-28","2021-01-15","2018-06-11",70,[497,498],"Cesarean Section Complications","Hemodynamic Instability",[476,500],"Carbetocin",{"trials":502,"activeCount":87},[],{"intervention":500,"totalTrials":83,"cells":504},{"EARLY_PHASE1":505,"PHASE1":507,"PHASE2":509,"PHASE3":511,"PHASE4":513,"NA":519},{"trials":506,"activeCount":87},[],{"trials":508,"activeCount":87},[],{"trials":510,"activeCount":87},[],{"trials":512,"activeCount":87},[],{"trials":514,"activeCount":87},[515],{"nctId":489,"briefTitle":490,"status":449,"phases":516,"primaryCompletion":492,"completion":493,"start":494,"enrollment":495,"conditions":517,"interventions":518},[79],[497,498],[476,500],{"trials":520,"activeCount":87},[],{"intervention":522,"totalTrials":83,"cells":523},"bolus of intravenous ketamine",{"EARLY_PHASE1":524,"PHASE1":526,"PHASE2":528,"PHASE3":530,"PHASE4":532,"NA":546},{"trials":525,"activeCount":87},[],{"trials":527,"activeCount":87},[],{"trials":529,"activeCount":87},[],{"trials":531,"activeCount":87},[],{"trials":533,"activeCount":87},[534],{"nctId":535,"briefTitle":536,"status":449,"phases":537,"primaryCompletion":538,"completion":539,"start":540,"enrollment":541,"conditions":542,"interventions":544},"NCT03781635","Comparison of BIS Index Variations: Bolus Versus Infusion Ketamine, and Impact on the Anesthesia Gas Consumption",[79],"2019-03-29","2019-09-30","2018-09-25",50,[543],"Bolus Versus Infusion Ketamine, Anesthesia Gas Consumption",[522,545],"continuous infusion of intravenous ketamine",{"trials":547,"activeCount":87},[],{"intervention":545,"totalTrials":83,"cells":549},{"EARLY_PHASE1":550,"PHASE1":552,"PHASE2":554,"PHASE3":556,"PHASE4":558,"NA":564},{"trials":551,"activeCount":87},[],{"trials":553,"activeCount":87},[],{"trials":555,"activeCount":87},[],{"trials":557,"activeCount":87},[],{"trials":559,"activeCount":87},[560],{"nctId":535,"briefTitle":536,"status":449,"phases":561,"primaryCompletion":538,"completion":539,"start":540,"enrollment":541,"conditions":562,"interventions":563},[79],[543],[522,545],{"trials":565,"activeCount":87},[],{"intervention":567,"totalTrials":83,"cells":568},"intravenous lidocaine",{"EARLY_PHASE1":569,"PHASE1":571,"PHASE2":573,"PHASE3":575,"PHASE4":577,"NA":589},{"trials":570,"activeCount":87},[],{"trials":572,"activeCount":87},[],{"trials":574,"activeCount":87},[],{"trials":576,"activeCount":87},[],{"trials":578,"activeCount":87},[579],{"nctId":580,"briefTitle":581,"status":233,"phases":582,"primaryCompletion":583,"completion":584,"start":585,"enrollment":332,"conditions":586,"interventions":588},"NCT03410836","Impact of Intravenous Lidocaine During Colorectal Surgery on Pain and Immune Functions",[79],"2024-12","2025-06","2019-04-29",[587],"Intravenous Lidocaine and Immunity",[567],{"trials":590,"activeCount":87},[],{"intervention":592,"totalTrials":83,"cells":593},"Neostigmine and glycopyrrolate",{"EARLY_PHASE1":594,"PHASE1":596,"PHASE2":598,"PHASE3":600,"PHASE4":602,"NA":615},{"trials":595,"activeCount":87},[],{"trials":597,"activeCount":87},[],{"trials":599,"activeCount":87},[],{"trials":601,"activeCount":87},[],{"trials":603,"activeCount":87},[604],{"nctId":605,"briefTitle":606,"status":449,"phases":607,"primaryCompletion":608,"completion":608,"start":609,"enrollment":610,"conditions":611,"interventions":613},"NCT05718934","Low Dose of Sugammadex vs Neostigmine and Glycopyrrolate for the Reversal of Rocuronium",[79],"2023-12-19","2022-11-08",144,[612],"Neuromuscular Blockade",[592,614],"Sugammadex",{"trials":616,"activeCount":87},[],{"intervention":614,"totalTrials":83,"cells":618},{"EARLY_PHASE1":619,"PHASE1":621,"PHASE2":623,"PHASE3":625,"PHASE4":627,"NA":633},{"trials":620,"activeCount":87},[],{"trials":622,"activeCount":87},[],{"trials":624,"activeCount":87},[],{"trials":626,"activeCount":87},[],{"trials":628,"activeCount":87},[629],{"nctId":605,"briefTitle":606,"status":449,"phases":630,"primaryCompletion":608,"completion":608,"start":609,"enrollment":610,"conditions":631,"interventions":632},[79],[612],[592,614],{"trials":634,"activeCount":87},[],{"intervention":636,"totalTrials":83,"cells":637},"Rocuronium IV bolus 0.1 mg\u002Fkg guided by TOF that must remain between 1-3 during surgery",{"EARLY_PHASE1":638,"PHASE1":640,"PHASE2":642,"PHASE3":644,"PHASE4":646,"NA":659},{"trials":639,"activeCount":87},[],{"trials":641,"activeCount":87},[],{"trials":643,"activeCount":87},[],{"trials":645,"activeCount":87},[],{"trials":647,"activeCount":87},[648],{"nctId":649,"briefTitle":650,"status":233,"phases":651,"primaryCompletion":652,"completion":652,"start":653,"enrollment":654,"conditions":655,"interventions":657},"NCT03910998","Impact of Intraoperative Deep Neuromuscular Blockade on NOL-guided Opioid Requirement in LSC Colorectal Surgeries",[79],"2022-07-01","2019-05-30",100,[656],"Laparoscopic Colorectal Surgeries",[636,658],"Rocuronium IV bolus 0.1 mg\u002Fkg guided by TOF 0\u002F4 and PTC≤ 2",{"trials":660,"activeCount":87},[],{"intervention":658,"totalTrials":83,"cells":662},{"EARLY_PHASE1":663,"PHASE1":665,"PHASE2":667,"PHASE3":669,"PHASE4":671,"NA":677},{"trials":664,"activeCount":87},[],{"trials":666,"activeCount":87},[],{"trials":668,"activeCount":87},[],{"trials":670,"activeCount":87},[],{"trials":672,"activeCount":87},[673],{"nctId":649,"briefTitle":650,"status":233,"phases":674,"primaryCompletion":652,"completion":652,"start":653,"enrollment":654,"conditions":675,"interventions":676},[79],[656],[636,658],{"trials":678,"activeCount":87},[],{"intervention":680,"totalTrials":83,"cells":681},"Intravenous Fentanyl guided by SoC+NOL",{"EARLY_PHASE1":682,"PHASE1":684,"PHASE2":686,"PHASE3":688,"PHASE4":690,"NA":705},{"trials":683,"activeCount":87},[],{"trials":685,"activeCount":87},[],{"trials":687,"activeCount":87},[],{"trials":689,"activeCount":87},[],{"trials":691,"activeCount":87},[692],{"nctId":693,"briefTitle":694,"status":449,"phases":695,"primaryCompletion":696,"completion":697,"start":698,"enrollment":495,"conditions":699,"interventions":703},"NCT03776838","Impact of Nociceptive-Level (NOL) Intraoperative Guided Analgesia During Gynecological Laparoscopic Surgery Under General Anesthesia",[79],"2019-12-06","2021-09-15","2018-11-30",[700,701,702],"Gynecologic Laparoscopic Surgery","Hysterectomy","Oophorectomy",[680,704],"Intravenous Fentanyl guided by SoC",{"trials":706,"activeCount":87},[],{"intervention":704,"totalTrials":83,"cells":708},{"EARLY_PHASE1":709,"PHASE1":711,"PHASE2":713,"PHASE3":715,"PHASE4":717,"NA":723},{"trials":710,"activeCount":87},[],{"trials":712,"activeCount":87},[],{"trials":714,"activeCount":87},[],{"trials":716,"activeCount":87},[],{"trials":718,"activeCount":87},[719],{"nctId":693,"briefTitle":694,"status":449,"phases":720,"primaryCompletion":696,"completion":697,"start":698,"enrollment":495,"conditions":721,"interventions":722},[79],[700,701,702],[680,704],{"trials":724,"activeCount":87},[],{"intervention":726,"totalTrials":9,"cells":727},"Cyproheptadine Hydrochloride 4 MG",{"EARLY_PHASE1":728,"PHASE1":730,"PHASE2":732,"PHASE3":747,"PHASE4":759,"NA":761},{"trials":729,"activeCount":87},[],{"trials":731,"activeCount":87},[],{"trials":733,"activeCount":87},[734],{"nctId":735,"briefTitle":736,"status":233,"phases":737,"primaryCompletion":738,"completion":739,"start":740,"enrollment":332,"conditions":741,"interventions":746},"NCT04876573","Pilot Study for Cyproheptadine in Hospitalized Patient for COVID-19",[77],"2021-12-31","2022-01-31","2021-06-01",[742,743,744,745],"Viral Pneumonia","COVID-19 Pneumonia","Serotonin Syndrome","Platelet Dysfunction",[726],{"trials":748,"activeCount":87},[749],{"nctId":750,"briefTitle":751,"status":233,"phases":752,"primaryCompletion":753,"completion":754,"start":755,"enrollment":756,"conditions":757,"interventions":758},"NCT04820751","Cyproheptadine in Severe COVID-19 : A Unblinded Randomized Trial",[78],"2021-11-01","2022-01-01","2021-04-10",200,[742,744,745],[726],{"trials":760,"activeCount":87},[],{"trials":762,"activeCount":87},[],{"intervention":764,"totalTrials":83,"cells":765},"Diphenhydramine",{"EARLY_PHASE1":766,"PHASE1":768,"PHASE2":770,"PHASE3":772,"PHASE4":794,"NA":796},{"trials":767,"activeCount":87},[],{"trials":769,"activeCount":87},[],{"trials":771,"activeCount":87},[],{"trials":773,"activeCount":87},[774],{"nctId":775,"briefTitle":776,"status":449,"phases":777,"primaryCompletion":778,"completion":779,"start":780,"enrollment":781,"conditions":782,"interventions":790},"NCT04237090","Feasibility of a Clinical Trial Comparing the Use of Cetirizine to Replace Diphenhydramine in the Prevention of Reactions Related to Paclitaxel",[78],"2020-08-28","2020-09-04","2020-02-14",27,[783,784,785,786,787,788,789],"Breast Cancer","Lung Cancer","Ovarian Cancer","Oesophageal Cancer","Head Cancer Neck","Cervical Cancer","Endometrial Cancer",[764,791,792,793],"Cetirizine","Lactose pill","Sodium chloride 0.9%",{"trials":795,"activeCount":87},[],{"trials":797,"activeCount":87},[],{"intervention":791,"totalTrials":83,"cells":799},{"EARLY_PHASE1":800,"PHASE1":802,"PHASE2":804,"PHASE3":806,"PHASE4":812,"NA":814},{"trials":801,"activeCount":87},[],{"trials":803,"activeCount":87},[],{"trials":805,"activeCount":87},[],{"trials":807,"activeCount":87},[808],{"nctId":775,"briefTitle":776,"status":449,"phases":809,"primaryCompletion":778,"completion":779,"start":780,"enrollment":781,"conditions":810,"interventions":811},[78],[783,784,785,786,787,788,789],[764,791,792,793],{"trials":813,"activeCount":87},[],{"trials":815,"activeCount":87},[],{"intervention":792,"totalTrials":83,"cells":817},{"EARLY_PHASE1":818,"PHASE1":820,"PHASE2":822,"PHASE3":824,"PHASE4":830,"NA":832},{"trials":819,"activeCount":87},[],{"trials":821,"activeCount":87},[],{"trials":823,"activeCount":87},[],{"trials":825,"activeCount":87},[826],{"nctId":775,"briefTitle":776,"status":449,"phases":827,"primaryCompletion":778,"completion":779,"start":780,"enrollment":781,"conditions":828,"interventions":829},[78],[783,784,785,786,787,788,789],[764,791,792,793],{"trials":831,"activeCount":87},[],{"trials":833,"activeCount":87},[],{"intervention":793,"totalTrials":83,"cells":835},{"EARLY_PHASE1":836,"PHASE1":838,"PHASE2":840,"PHASE3":842,"PHASE4":848,"NA":850},{"trials":837,"activeCount":87},[],{"trials":839,"activeCount":87},[],{"trials":841,"activeCount":87},[],{"trials":843,"activeCount":87},[844],{"nctId":775,"briefTitle":776,"status":449,"phases":845,"primaryCompletion":778,"completion":779,"start":780,"enrollment":781,"conditions":846,"interventions":847},[78],[783,784,785,786,787,788,789],[764,791,792,793],{"trials":849,"activeCount":87},[],{"trials":851,"activeCount":87},[],{"intervention":853,"totalTrials":83,"cells":854},"ECT-001 (UM171) expanded cord blood",{"EARLY_PHASE1":855,"PHASE1":857,"PHASE2":859,"PHASE3":872,"PHASE4":874,"NA":876},{"trials":856,"activeCount":87},[],{"trials":858,"activeCount":87},[],{"trials":860,"activeCount":87},[861],{"nctId":862,"briefTitle":863,"status":449,"phases":864,"primaryCompletion":865,"completion":866,"start":867,"enrollment":868,"conditions":869,"interventions":871},"NCT03441958","ECT-001 (UM171) Expanded Cord Blood Transplant to Treat High-risk Multiple Myeloma",[76,77],"2023-10-28","2025-10-17","2018-03-07",19,[870],"Multiple Myeloma",[853],{"trials":873,"activeCount":87},[],{"trials":875,"activeCount":87},[],{"trials":877,"activeCount":87},[],{"intervention":879,"totalTrials":83,"cells":880},"GLIDE",{"EARLY_PHASE1":881,"PHASE1":883,"PHASE2":885,"PHASE3":906,"PHASE4":908,"NA":910},{"trials":882,"activeCount":87},[],{"trials":884,"activeCount":87},[],{"trials":886,"activeCount":87},[887],{"nctId":888,"briefTitle":889,"status":233,"phases":890,"primaryCompletion":891,"completion":892,"start":893,"enrollment":894,"conditions":895,"interventions":905},"NCT03091933","Antiminor Histocompatibility Complex (MiHA) T Cells for Patients With Relapsed Hematologic Malignancies Following Matched HSCT (Guided Lymphocyte Immunopeptide Derived Expansion)",[76,77],"2018-03-31","2019-03-31","2017-02-06",20,[896,897,898,899,900,901,902,903,904],"Hematologic Cancer","Relapse Leukemia","Relapsed Adult ALL","Relapsed Adult AML","Relapsed CLL","Relapsed Non Hodgkin Lymphoma","Relapsed Hodgkin's Lymphoma","Relapsed Myelodysplastic Syndromes","Relapsed Multiple Myeloma",[879],{"trials":907,"activeCount":87},[],{"trials":909,"activeCount":87},[],{"trials":911,"activeCount":87},[],{"intervention":913,"totalTrials":83,"cells":914},"Application of 0.02% MMC over 60 seconds post corneal crosslinking.",{"EARLY_PHASE1":915,"PHASE1":917,"PHASE2":919,"PHASE3":932,"PHASE4":934,"NA":936},{"trials":916,"activeCount":87},[],{"trials":918,"activeCount":87},[],{"trials":920,"activeCount":87},[921],{"nctId":922,"briefTitle":923,"status":924,"phases":925,"primaryCompletion":926,"completion":926,"start":927,"enrollment":19,"conditions":928,"interventions":930},"NCT04811924","The Effect of Mitomycin C on Corneal Haze and Scarring After Corneal Crosslinking in Keratoconus Patients","TERMINATED",[77],"2023-02-22","2021-07-26",[929],"Keratoconus",[913,931],"Corneal crosslinking without the application of 0.02% MMC",{"trials":933,"activeCount":87},[],{"trials":935,"activeCount":87},[],{"trials":937,"activeCount":87},[],{"intervention":931,"totalTrials":83,"cells":939},{"EARLY_PHASE1":940,"PHASE1":942,"PHASE2":944,"PHASE3":950,"PHASE4":952,"NA":954},{"trials":941,"activeCount":87},[],{"trials":943,"activeCount":87},[],{"trials":945,"activeCount":87},[946],{"nctId":922,"briefTitle":923,"status":924,"phases":947,"primaryCompletion":926,"completion":926,"start":927,"enrollment":19,"conditions":948,"interventions":949},[77],[929],[913,931],{"trials":951,"activeCount":87},[],{"trials":953,"activeCount":87},[],{"trials":955,"activeCount":87},[],{"intervention":957,"totalTrials":83,"cells":958},"Lenalidomide-Dexamethasone-DLI",{"EARLY_PHASE1":959,"PHASE1":961,"PHASE2":963,"PHASE3":975,"PHASE4":977,"NA":979},{"trials":960,"activeCount":87},[],{"trials":962,"activeCount":87},[],{"trials":964,"activeCount":87},[965],{"nctId":966,"briefTitle":967,"status":449,"phases":968,"primaryCompletion":969,"completion":969,"start":970,"enrollment":971,"conditions":972,"interventions":974},"NCT03413800","Len\u002FDex\u002FDLI in Relapsed Multiple Myeloma After Allogeneic Stem Cell Transplant",[77],"2024-03-27","2018-02-12",10,[973,870],"Relapsed Hematologic Malignancy",[957],{"trials":976,"activeCount":87},[],{"trials":978,"activeCount":87},[],{"trials":980,"activeCount":87},[],{"intervention":982,"totalTrials":83,"cells":983},"Citalopram 20mg or 40 mg",{"EARLY_PHASE1":984,"PHASE1":986,"PHASE2":988,"PHASE3":1000,"PHASE4":1002,"NA":1004},{"trials":985,"activeCount":87},[],{"trials":987,"activeCount":87},[],{"trials":989,"activeCount":87},[990],{"nctId":991,"briefTitle":992,"status":449,"phases":993,"primaryCompletion":994,"completion":994,"start":995,"enrollment":996,"conditions":997,"interventions":999},"NCT03899285","Citalopram Titration in Early Non-responder Patients With Major Depressive Disorders",[77],"2018-12-08","2018-01-08",8,[998],"Major Depressive Disorder",[982],{"trials":1001,"activeCount":87},[],{"trials":1003,"activeCount":87},[],{"trials":1005,"activeCount":87},[],{"intervention":1007,"totalTrials":83,"cells":1008},"EBV-specific T cells",{"EARLY_PHASE1":1009,"PHASE1":1011,"PHASE2":1013,"PHASE3":1015,"PHASE4":1017,"NA":1019},{"trials":1010,"activeCount":87},[],{"trials":1012,"activeCount":87},[],{"trials":1014,"activeCount":87},[],{"trials":1016,"activeCount":87},[],{"trials":1018,"activeCount":87},[],{"trials":1020,"activeCount":87},[1021],{"nctId":1022,"briefTitle":1023,"status":449,"phases":1024,"primaryCompletion":1025,"completion":1025,"start":1026,"enrollment":83,"conditions":1027,"interventions":1029},"NCT06391814","Donor-Derived EBV-Specific T Cells for Life Threatening EBV-lymphoma (OLIP-EBV-TCL-01-HMR01)",[80],"2025-04-05","2024-01-16",[1028],"EBV Associated Lymphoma",[1007],{"intervention":1031,"totalTrials":83,"cells":1032},"Continuous perineural infusion of ropivacaine 0.2% 5 ml\u002Fh for 48 h",{"EARLY_PHASE1":1033,"PHASE1":1035,"PHASE2":1037,"PHASE3":1039,"PHASE4":1041,"NA":1043},{"trials":1034,"activeCount":87},[],{"trials":1036,"activeCount":87},[],{"trials":1038,"activeCount":87},[],{"trials":1040,"activeCount":87},[],{"trials":1042,"activeCount":87},[],{"trials":1044,"activeCount":87},[1045],{"nctId":1046,"briefTitle":1047,"status":924,"phases":1048,"primaryCompletion":1049,"completion":1049,"start":1050,"enrollment":9,"conditions":1051,"interventions":1052},"NCT03990038","Comparison of Two Multimodal Analgesia Regimens in Total Knee Arthroplasty",[80],"2019-10-01","2019-08-01",[24],[1031,1053],"Extended Release",{"intervention":1053,"totalTrials":83,"cells":1055},{"EARLY_PHASE1":1056,"PHASE1":1058,"PHASE2":1060,"PHASE3":1062,"PHASE4":1064,"NA":1066},{"trials":1057,"activeCount":87},[],{"trials":1059,"activeCount":87},[],{"trials":1061,"activeCount":87},[],{"trials":1063,"activeCount":87},[],{"trials":1065,"activeCount":87},[],{"trials":1067,"activeCount":87},[1068],{"nctId":1046,"briefTitle":1047,"status":924,"phases":1069,"primaryCompletion":1049,"completion":1049,"start":1050,"enrollment":9,"conditions":1070,"interventions":1071},[80],[24],[1031,1053],{"intervention":1073,"totalTrials":83,"cells":1074},"Intrathecal Morphine",{"EARLY_PHASE1":1075,"PHASE1":1077,"PHASE2":1079,"PHASE3":1081,"PHASE4":1083,"NA":1085},{"trials":1076,"activeCount":87},[],{"trials":1078,"activeCount":87},[],{"trials":1080,"activeCount":87},[],{"trials":1082,"activeCount":87},[],{"trials":1084,"activeCount":87},[],{"trials":1086,"activeCount":87},[1087],{"nctId":1088,"briefTitle":1089,"status":1090,"phases":1091,"primaryCompletion":1092,"completion":1093,"start":1094,"enrollment":87,"conditions":1095,"interventions":1098},"NCT05696678","Improving ObsQoR-11 With Continuous Wound Infusion Versus Intrathecal Morphine After Elective Cesarean Delivery","WITHDRAWN",[80],"2023-08","2023-11","2023-02",[1096,15,24,1097],"Quality of Recovery","Cesarean Section",[1073,1099],"Ropivacaine 0.2%",{"intervention":1099,"totalTrials":83,"cells":1101},{"EARLY_PHASE1":1102,"PHASE1":1104,"PHASE2":1106,"PHASE3":1108,"PHASE4":1110,"NA":1112},{"trials":1103,"activeCount":87},[],{"trials":1105,"activeCount":87},[],{"trials":1107,"activeCount":87},[],{"trials":1109,"activeCount":87},[],{"trials":1111,"activeCount":87},[],{"trials":1113,"activeCount":87},[1114],{"nctId":1088,"briefTitle":1089,"status":1090,"phases":1115,"primaryCompletion":1092,"completion":1093,"start":1094,"enrollment":87,"conditions":1116,"interventions":1117},[80],[1096,15,24,1097],[1073,1099],{"intervention":1119,"totalTrials":83,"cells":1120},"Remifentanil infusion, desflurane titration and fluid infusion will be guided by NOL index, BIS index and Flotrac EV1000 system respectively",{"EARLY_PHASE1":1121,"PHASE1":1123,"PHASE2":1125,"PHASE3":1127,"PHASE4":1129,"NA":1131},{"trials":1122,"activeCount":87},[],{"trials":1124,"activeCount":87},[],{"trials":1126,"activeCount":87},[],{"trials":1128,"activeCount":87},[],{"trials":1130,"activeCount":87},[],{"trials":1132,"activeCount":87},[1133],{"nctId":1134,"briefTitle":1135,"status":924,"phases":1136,"primaryCompletion":1137,"completion":1137,"start":1138,"enrollment":1139,"conditions":1140,"interventions":1144},"NCT04104334","Impact of an Optimised Monitored Anesthesia on the Patients' Recovery After Cytoreduction Surgery Plus HIPEC",[80],"2020-11-30","2019-05-08",9,[1141,1142,1143],"Hyperthermia","Colorectal Neoplasms","Oxaliplatin",[1119,1145],"Remifentanil infusion and desflurane titration will be guided by anesthesia usual practices",{"intervention":1145,"totalTrials":83,"cells":1147},{"EARLY_PHASE1":1148,"PHASE1":1150,"PHASE2":1152,"PHASE3":1154,"PHASE4":1156,"NA":1158},{"trials":1149,"activeCount":87},[],{"trials":1151,"activeCount":87},[],{"trials":1153,"activeCount":87},[],{"trials":1155,"activeCount":87},[],{"trials":1157,"activeCount":87},[],{"trials":1159,"activeCount":87},[1160],{"nctId":1134,"briefTitle":1135,"status":924,"phases":1161,"primaryCompletion":1137,"completion":1137,"start":1138,"enrollment":1139,"conditions":1162,"interventions":1163},[80],[1141,1142,1143],[1119,1145],{"intervention":1165,"totalTrials":83,"cells":1166},"Biomarkers",{"EARLY_PHASE1":1167,"PHASE1":1169,"PHASE2":1171,"PHASE3":1173,"PHASE4":1175,"NA":1177},{"trials":1168,"activeCount":87},[],{"trials":1170,"activeCount":87},[],{"trials":1172,"activeCount":87},[],{"trials":1174,"activeCount":87},[],{"trials":1176,"activeCount":87},[],{"trials":1178,"activeCount":87},[1179],{"nctId":1180,"briefTitle":1181,"status":924,"phases":1182,"primaryCompletion":1183,"completion":1183,"start":1184,"enrollment":1185,"conditions":1186,"interventions":1189},"NCT03422783","Correlation Between NOL Index After Stimulus and Post-operative Opioid, Pain, Pre-operative Phenotype",[80],"2024-03-07","2018-01-15",31,[1187,15,1188,18],"Pain, Postoperative","Catastrophizing",[1165],{"intervention":1191,"totalTrials":83,"cells":1192},"Remifentanil dose 0.5 ug\u002Fkg",{"EARLY_PHASE1":1193,"PHASE1":1195,"PHASE2":1197,"PHASE3":1199,"PHASE4":1201,"NA":1203},{"trials":1194,"activeCount":87},[],{"trials":1196,"activeCount":87},[],{"trials":1198,"activeCount":87},[],{"trials":1200,"activeCount":87},[],{"trials":1202,"activeCount":87},[],{"trials":1204,"activeCount":87},[1205],{"nctId":1206,"briefTitle":1207,"status":449,"phases":1208,"primaryCompletion":1209,"completion":1210,"start":1211,"enrollment":1212,"conditions":1213,"interventions":1215},"NCT03744949","ED50 and ED95 of Remifentanil for Intubation Without NOL Variation",[80],"2018-10-19","2021-09-30","2018-03-14",80,[1214],"Intubation; Difficult or Failed",[1191,1216,1217,1218],"Remifentanil dose 1 ug\u002Fkg","Remifentanil dose 1.5 ug\u002Fkg","Remifentanil dose 2 ug\u002Fkg",{"intervention":1216,"totalTrials":83,"cells":1220},{"EARLY_PHASE1":1221,"PHASE1":1223,"PHASE2":1225,"PHASE3":1227,"PHASE4":1229,"NA":1231},{"trials":1222,"activeCount":87},[],{"trials":1224,"activeCount":87},[],{"trials":1226,"activeCount":87},[],{"trials":1228,"activeCount":87},[],{"trials":1230,"activeCount":87},[],{"trials":1232,"activeCount":87},[1233],{"nctId":1206,"briefTitle":1207,"status":449,"phases":1234,"primaryCompletion":1209,"completion":1210,"start":1211,"enrollment":1212,"conditions":1235,"interventions":1236},[80],[1214],[1191,1216,1217,1218],{"intervention":1217,"totalTrials":83,"cells":1238},{"EARLY_PHASE1":1239,"PHASE1":1241,"PHASE2":1243,"PHASE3":1245,"PHASE4":1247,"NA":1249},{"trials":1240,"activeCount":87},[],{"trials":1242,"activeCount":87},[],{"trials":1244,"activeCount":87},[],{"trials":1246,"activeCount":87},[],{"trials":1248,"activeCount":87},[],{"trials":1250,"activeCount":87},[1251],{"nctId":1206,"briefTitle":1207,"status":449,"phases":1252,"primaryCompletion":1209,"completion":1210,"start":1211,"enrollment":1212,"conditions":1253,"interventions":1254},[80],[1214],[1191,1216,1217,1218],{"intervention":1218,"totalTrials":83,"cells":1256},{"EARLY_PHASE1":1257,"PHASE1":1259,"PHASE2":1261,"PHASE3":1263,"PHASE4":1265,"NA":1267},{"trials":1258,"activeCount":87},[],{"trials":1260,"activeCount":87},[],{"trials":1262,"activeCount":87},[],{"trials":1264,"activeCount":87},[],{"trials":1266,"activeCount":87},[],{"trials":1268,"activeCount":87},[1269],{"nctId":1206,"briefTitle":1207,"status":449,"phases":1270,"primaryCompletion":1209,"completion":1210,"start":1211,"enrollment":1212,"conditions":1271,"interventions":1272},[80],[1214],[1191,1216,1217,1218],{"intervention":1274,"totalTrials":83,"cells":1275},"single shot interscalene brachial plexus block group with dexmedetomidine added to ropivacaine group",{"EARLY_PHASE1":1276,"PHASE1":1278,"PHASE2":1280,"PHASE3":1282,"PHASE4":1284,"NA":1286},{"trials":1277,"activeCount":87},[],{"trials":1279,"activeCount":87},[],{"trials":1281,"activeCount":87},[],{"trials":1283,"activeCount":87},[],{"trials":1285,"activeCount":87},[],{"trials":1287,"activeCount":87},[1288],{"nctId":1289,"briefTitle":1290,"status":233,"phases":1291,"primaryCompletion":1292,"completion":584,"start":1293,"enrollment":1294,"conditions":1295,"interventions":1298},"NCT05775861","Dexmedetomidine Added to Ropivacaine Single Shot vs Continuous Interscalene Nerve Block",[80],"2025-01","2022-08-23",96,[15,1296,1297],"Shoulder Pain","Post Operative Pain",[1274,1299],"continuous interscalene brachial plexus block",{"intervention":1299,"totalTrials":83,"cells":1301},{"EARLY_PHASE1":1302,"PHASE1":1304,"PHASE2":1306,"PHASE3":1308,"PHASE4":1310,"NA":1312},{"trials":1303,"activeCount":87},[],{"trials":1305,"activeCount":87},[],{"trials":1307,"activeCount":87},[],{"trials":1309,"activeCount":87},[],{"trials":1311,"activeCount":87},[],{"trials":1313,"activeCount":87},[1314],{"nctId":1289,"briefTitle":1290,"status":233,"phases":1315,"primaryCompletion":1292,"completion":584,"start":1293,"enrollment":1294,"conditions":1316,"interventions":1317},[80],[15,1296,1297],[1274,1299],{"intervention":1319,"totalTrials":83,"cells":1320},"Bupivacaine",{"EARLY_PHASE1":1321,"PHASE1":1323,"PHASE2":1325,"PHASE3":1327,"PHASE4":1329,"NA":1331},{"trials":1322,"activeCount":87},[],{"trials":1324,"activeCount":87},[],{"trials":1326,"activeCount":87},[],{"trials":1328,"activeCount":87},[],{"trials":1330,"activeCount":87},[],{"trials":1332,"activeCount":87},[1333],{"nctId":1334,"briefTitle":1335,"status":233,"phases":1336,"primaryCompletion":1337,"completion":1338,"start":1339,"enrollment":1340,"conditions":1341,"interventions":1344},"NCT05967936","Paracervical Block Versus Transcervical Block in Outpatient Procedural Hysteroscopy",[80],"2024-09-01","2024-12-01","2023-09-01",242,[1342,1343],"Myoma;Uterus","Polyp Uterus",[1319]]